• 1
    Heringer-Walther S, Moreira Mda C, Wessel N, et al. Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies? J Cardiovasc Pharmacol 2006;48:293298.
  • 2
    O'Sullivan ML, O'Grady MR, Minors SL. Plasma big endothelin-1, atrial natriuretic peptide, aldosterone, and norepinephrine concentrations in normal Doberman Pinschers and Doberman Pinschers with dilated cardiomyopathy. J Vet Intern Med 2007;21:9299.
  • 3
    Oyama MA, Sisson DD. Cardiac troponin-I concentration in dogs with cardiac disease. J Vet Intern Med 2004;18:831839.
  • 4
    Oyama MA, Sisson DD, Solter PF. Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations. Am J Vet Res 2007;68:4247.
  • 5
    Biondo AW, Liu ZL, Wiedmeyer CE, et al. Genomic sequence and cardiac expression of atrial natriuretic peptide in cats. Am J Vet Res 2002;63:236240.
  • 6
    Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003;24:341356, (review).
  • 7
    Gottlieb SS, Kukin ML, Ahern D, et al. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989;13:15341539.
  • 8
    Grzybowski J, Bilinska ZT, Janas J, et al. Plasma concentrations of N-terminal atrial natriuretic peptide are raised in asymptomatic relatives of dilated cardiomyopathy patients with left ventricular enlargement. Heart 2002;88:191192.
  • 9
    Rouleau JL, Packer M, Moye L, et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: Effect of captopril. J Am Coll Cardiol 1994;24:583591.
  • 10
    Asano K, Masuda K, Okumura M, et al. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure. J Vet Med Sci 1999;61:523529.
  • 11
    Cheung MM, Smallhorn JF, Redington AN, et al. The effects of changes in loading conditions and modulation of inotropic state on the myocardial performance index: Comparison with conductance catheter measurements. Eur Heart J 2004;25:22382242.
  • 12
    Fox SM. Textbook of Canine and Feline Cardiology, 2nd ed. Philadelphia: WB Saunders Company; 1999.
  • 13
    Fox PR, Lui SK, Maron BJ. Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease. Circulation 1995;92:26452651.
  • 14
    Nelson RW, Couto CG. Small Animal Internal Medicine, 3rd ed. St Louis: Mosby; 2003.
  • 15
    Ferasin L, Sturgess CP, Cannon MJ, et al. Feline idiopathic cardiomyopathy: A retrospective study of 106 cats (1994–2001). J Feline Med Surg 2003;5:151159.
  • 16
    Harada K, Tamura M, Toyono M, et al. Effect of dobutamine on a Doppler echocardiographic index of combined systolic and diastolic performance. Pediatr Cardiol 2002;23:613617.
  • 17
    Dzimiri N, Moorji A, Afrane B, et al. Differential regulation of atrial and brain natriuretic peptides and its implications for the management of left ventricular volume overload. Eur J Clin Invest 2002;32:563569.
  • 18
    Borgeson DD, Stevens TL, Heublein DM, et al. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: Functional cardiorenal responses to receptor antagonism. Clin Sci (London) 1998;95:195202.
  • 19
    Biondo AW, Ehrhart EJ, Sisson DD, et al. Immunohistochemistry of atrial and brain natriuretic peptides in control cats and cats with hypertrophic cardiomyopathy. Vet Pathol 2003;40:501506.
  • 20
    Matsumoto N, Akaike M, Nishiuchi T, et al. Different secretion profiles of atrial and brain natriuretic peptides after acute volume loading in patients with ischemic heart disease. Acta Cardiol 1997;52:261272.
  • 21
    Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001;12:15081515.
  • 22
    Greco DS, Biller B, Van Liew CH. Measurement of plasma atrial natriuretic peptide as an indicator of prognosis in dogs with cardiac disease. Can Vet J 2003;44:293297.
  • 23
    MacLean HN, Abbott JA, Ward DL, et al. N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy. J Vet Intern Med 2006;20:284289.
  • 24
    Holmstrom H, Hall C, Stokke TO, et al. Plasma levels of N-terminal proatrial natriuretic peptide in children are dependent on renal function and age. Scand J Clin Lab Invest 2000;60:149159.